Jaka jest cena za Alimera Sciences, Inc. (ALIM)

Cena za Alimera Sciences, Inc. (ALIM) wynosi $5.54

Jaka jest kapitalizacja rynkowa dla Alimera Sciences, Inc. (ALIM)

Kapitalizacja rynkowa dla Alimera Sciences, Inc. (ALIM) wynosi $38.76M

Alimera Sciences, Inc. (ALIM) Podziały Akcji

Alimera Sciences, Inc. is a pharmaceutical company focused on developing and commercializing ophthalmic treatments globally, including in the United States. Its primary offering, ILUVIEN, is an intravitreal implant used to manage diabetic macular edema (DME), a severe retinal disease in individuals with diabetes that can lead to profound vision loss and blindness. Additionally, ILUVIEN helps prevent relapses of recurrent non-infectious uveitis affecting the posterior segment of the eye. The company distributes its products directly and through distributors to various healthcare entities such as physician offices, pharmacies, and hospitals. Alimera also maintains a collaboration with EyePoint Pharmaceuticals US, Inc. focused on developing and marketing insert technology. This technology is designed to deliver corticosteroids to the back of the eye for treating and preventing various human eye diseases, including diabetic macular edema. Founded in 2003, Alimera Sciences is headquartered in Alpharetta, Georgia.

Rok	Podział	Mnożnik	Skumulowany mnożnik
2019-11-15	1:15	x0.066666666666667	x0.066666666666667

Rok

Podział

Mnożnik

Skumulowany mnożnik

2019-11-15

1:15

x0.066666666666667

Firma	Liczba podziałów akcji	Skumulowany mnożnik	Kraj
MERCK Kommanditgesellschaft auf Aktien MER.SW	0	-	DE
Merck KGaA MRK.DE	0	-	DE
Takeda Pharmaceutical Company Limited 4502.T	0	-	JP
Galderma Group AG GALD.SW	0	-	CH
Sun Pharmaceutical Industries Limited SUNPHARMA.NS	5	x119	IN

Firma

Liczba podziałów akcji

Skumulowany mnożnik

Kraj